Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
Background. The main factors that increase the risk of cardiovascular accidents and mortality among patients with COVID-19 include hyperglycemia, arterial hypertension and dyslipidemia. Therefore, all patients with COVID-19 and metabolic syndrome should receive antihypertensive (AHT), hypolipidemic...
Guardado en:
Autores principales: | Tatiana Yu. Demidova, Kristina G. Lobanova, Sergey N. Perekhodov, Michail B. Antsiferov, Olga S. Oynotkinova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
"Consilium Medicum" Publishing house
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a324d85d2b694f45bd8dce55506f770a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expert consensus. Effect of antihypertensive therapy on cognitive functions
por: Olga D. Ostroumova, et al.
Publicado: (2021) -
CERIMETRIC DETERMINATION OF FOUR ANTIHYPERTENSIVE DRUGS IN PHARMACEUTICAL PREPARATIONS
por: EL-DIDAMONY,A.M, et al.
Publicado: (2011) -
The place of fixed antihypertensive drugs in modern therapy of arterial hypertension
por: Tatiana V. Pinchuk, et al.
Publicado: (2021) -
Antihypertensive drug prescription trends in Shahrekord, Iran
por: Ahmadreza Maghsoudi, et al.
Publicado: (2022) -
Frequency of Iatrogenic Sexual Dysfunction Associated with Antihypertensive Compounds
por: Bárbara Buch-Vicente, et al.
Publicado: (2021)